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Objectives. Proximity of ureters with iliac arteries makes them prone to damage by aorto-iliac pathology or surgery. The
aim of this retrospective study is to analyse the incidence, the predisposing factors, and the optimal treatment of ureteral
stenosis (US) or leakages (UL).
Design. Retrospective study.
Material. Fiftyone ureteral lesions in 41 patients referred to the urologist in a fourteen years period in the same institution.
Methods. Lesions are classified in three groups: A, preoperative; B, less than 3 months postoperatively; and C, more than 3
months postoperatively. Group A comprises 10 abdominal aortic aneurysm (AAA) patients; eight of the AAA are of the
inflammatory type. Group B comprises 16 patients, 11 US and 9 UL. Group C comprises 15 patients and 15 US.
Results. Endoureteral treatment was successful in most of the group B patients. Some of them, however, had to be submitted
to secondary open surgery, so that the global success rate is 70% in group B. In group C, the response is poor following
endourological treatment alone (12.5% success) and open surgery is more often needed (3 ureterolyses and 1 nephrectomy).
Global success rate is 40%.
Conclusion. Early diagnosis is associated to better results with less invasive procedure; late diagnosis is accompanied by a
lower success rate of endourological treatment and requires more often primary open surgery.
Key Words: Abdominal aortic aneurysm; Inflammatory abdominal aortic aneurysm; Ureterolysis; Percutaneous
nephrostomies; Urovascular fistula; Endoureteral catheter; Vascular prosthesis infection.
Introduction
Ureteral iatrogenic lesions encountered by urologists
correspond in the first instance to cases of their own
speciality and then to those derived from abdominal
and gynaecological surgery.1 – 3 At last, very few derive
from vascular surgery.4 – 6 Ureteral lesions from vas-
cular surgery would account for 0.8% of lesions
recognised at time of surgery and 2.2% of compli-
cations observed later.7 According to others,8 vascular
surgery would be responsible for 6.1% of iatrogenic
lesions. Though infrequent, they can be extremely
serious. Ureteral lesions from aorto-iliac pathology are
not all iatrogenic; some may be present prior to the
surgical procedure. They are related to the aneurysmal
form of the aortic pathology.9 Moreover, besides
lesions arising at time of surgery from iatrogenic
accidents, some are developing from inflammatory
secondary reactions. The aim of this One Centre
retrospective study is to analyse the occurrence rate
of ureteral lesions, the predisposing factors, the
modalities of the diagnosis, and the results of applied
therapies, so that one can define an optimal treatment
policy.
Material and methods
During a period of fourteen years, from 01/04/1986 to
01/04/2000, we encountered 41 vascular patients
presenting, prior or post-aorto-iliac surgery, a uni-
ðn ¼ 31Þ or bilateral ðn ¼ 10Þ ureteral problem, thus a
total of 51 ureters. There were 31 men and 10 women,
with a mean age of 70.5 years for men and 60.5 years
for women. During the same period, 2297 patients
underwent an aorto-iliac operation, either for an
obstructive pathology ðn ¼ 1159Þ; or for an aneurysmal
pathology ðn ¼ 1132Þ: The aneurysm group includes
40 inflammatory type aneurysms. The incidence of
ureteral lesions (uni- or bilateral) observed is 1.8%
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(41/2297). If we subtract the 10 patients with pre-
operative ureteral lesions, the occurrence rate falls to
1.3% (31/2287).
The series is analysed in three groups defined by the
timing of occurrence of the urological problem: group
A (lesions observed in the preoperative period), group
B (lesions observed at the time of operation or in the
early postoperative period (less than 3 months)) and
group C (lesions observed late postoperatively (more
than 3 months)).
Results
Type of lesions
The lesions are either pure ureteral stenoses (US) ðn ¼
42Þ or urinary leakage (UL) ðn ¼ 9Þ: Group A has 16 US
in 10 patients; group B has 11 US and 9 UL in sixteen
patients, and group C 15 patients and 15 US. The
preoperative ureteral pathology appears in patients
with aneurysm pathology only (10/10); the post-
operative ureteral lesions appeared after surgery for
aneurysm in 17 patients (17/1122, 1.5%) and after
surgery for obstructive aorto-iliac lesions in 14 patients
(14/1159, 1.2%).
Topography of ureteral lesions
The stenotic lesions (US) sit in the lumbar region in
seven cases out of 42 (16.6%): three on the right and
four on the left (Table 1). Five of the lumbar US are
present in the preoperative period (group A) and are
seen as part of aneurysm pathology (inflammatory,
n ¼ 3 or non-inflammatory, n ¼ 2). Two other lumbar
US occur late (group C) after surgery, one because of
periprosthesis fibrosis, and the other because of
development of a false aneurysm on the upper aortic
suture squeezing the ureteral paths (Fig. 1).
The other US ðn ¼ 35Þ are situated in the pelvic area.
UL ðn ¼ 9Þ are found only in pelvic area.
Diagnosis
Diagnosis is established differently in the 3 groups.
In group A, either uretero-hydronephrosis is
observed on the CT-Scan performed for evaluation of
a known aneurysm ðn ¼ 7Þ or, on the contrary, an
aneurysm is observed during evaluation of uretero-
hydronephrosis referred to the urologist ðn ¼ 3Þ:
In group B, only one UL is recognised at the time of
operation. In the eight other cases, either pyrexia ðn ¼ 5Þ;
ileus ðn ¼ 1Þ or/and urine found in a drainage catheter
ðn ¼ 8Þ leads to diagnosis. In the US cases, creatinine
increase is the diagnostic clue once only (one patient,
two ureters). In the other cases, the ureteral problem is
suspected on ultrasound performed for a variety of
problems (six patients, nine ureters).
In group C, the late US are observed either at the
time of a control radiographic exam ðn ¼ 8Þ; or because
of renal insufficiency ðn ¼ 6Þ; or of haematuria ðn ¼ 1Þ:
Factors predisposing to ureteral lesion
Inflammatory aneurysm
The preoperative lesions (10) are all related to the
presence of an abdominal aortic aneurysm (AAA).
Table 1. Topography of the ureteral lesions.
Lumbar Pelvic
Group A 5 11
Group B
US 0 11
UL 0 9
Group C 2 13
Total 7 44
US, stenosis; UL, leakage.
Fig. 1. Compression of left lumbar ureter (B) by the pseudo-
aneurysm (A) arising from the upper aortic anastomosis.
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Eight AAA out of 10 were inflammatory. In a total of 40
inflammatory AAA, this represents a 20% prevalence
rate (8/40) vs. 0.2% (2/1092) in patients with a non-
inflammatory AAA ðp , 0:0001Þ (Chi square test)
(Table 2).
History of previous surgery
Among 2297 operated patients, 10 have a ureteral
lesion prior to surgery, 2287 do not. Among these, 90
(4.1%) already have had a vascular operation at the
same anatomic site. Eleven of these 90 patients have a
pre- or postoperative ureteral problems (12.2%);
among them, eight post-surgery for obstructive ather-
osclerosis and three for aneurysm surgery. On the
contrary, in the population with no previous surgery at
this anatomic site ðn ¼ 2197Þ; 20 patients, only,
demonstrate a pre- or postoperative ureteral problems
(0.9%) ðp , 0:0001Þ (Chi square test) (Table 2).
Prosthesis infection
Three patients with ureteral problems have infection
of their arterial prosthesis. The total number of
patients affected with infection of the prosthesis
(other than these isolated at the groin) account for 18
patients; therefore, the prevalence of ureteral lesions is
3/18 (16.6%) vs. 1.2% in not apparently infected grafts
ðp , 0:001Þ (Chi square test) (Table 2).
Prosthesis malposition
In four cases, stenosis is accompanied by incorrect
position of the prosthesis, which is situated in front of
the ureter (these four cases are treated by ureterolysis
and repositioning of the ureters, by severing and
reanastomosing the vascular prosthesis). Prosthesis
malposition is observed after repair of AAA in two
cases and after reconstruction for obstructive vascular
disease in two cases.
Treatment modalities and results
Therapeutic policies applied in the three groups
appear in Table 3.
. Percutaneous nephrostomy ðn ¼ 6Þ; double JJ-pigtail
catheter ðn ¼ 23Þ and combined nephrostomy and
pigtail catheter ðn ¼ 7Þ:
. Treatment by open surgery: nephrectomy (primary
n ¼ 4 or secondary n ¼ 1), ureterolysis with or
without ureteral resection (primary ureterolysis,
n ¼ 7; secondary ureterolysis, n ¼ 10). Four ureter-
olyses are associated with uncrossing of a vascular
prosthesis.
. Surgical abstention if the kidney has no function
ðn ¼ 2Þ or in minor cases ðn ¼ 2Þ:
Group A (10 patients, 16 ureteral lesions). Five
nephrostomies and nine JJ-stents are placed at the time
of surgery and one primary ureterolysis is performed
during the vascular intervention. Among these five
nephrostomies, one secondary ureterolysis is there-
after necessary. Among the nine JJ ureteral stented US,
two secondary ureterolyses are performed. There is no
nephrectomy in this group and one patient needs
nothing but a short preoperative corticosteroid
therapy. In the long term, out of these 16 renal units,
11 are preserved (69%), three demonstrate chronic
renal stasis (19%) and two have no remaining function
(12%) (Tables 3 and 4).
Group B (16 patients, 20 ureteral lesions hence, 11 US
(7 patients) and nine UL (9 patients). The 11 US are
treated by corticosteroid therapy ðn ¼ 1Þ; primary
ureterolysis ðn ¼ 3Þ and JJ-stenting ðn ¼ 7Þ: In the
seven patients initially treated by JJ-stenting (one
associated with nephrostomy), three secondary open
ureterolyses are necessary (3/7). Also prolonged
pigtail, more than six months, in two patients is
responsible for one uretero-prosthetic fistula and one
uretero-arterial (retrogradely perfused iliac aneurysm)
(Fig. 2). The nine UL are treated as follows: two
primary nephrectomies and seven endoureteral cath-
eters (four associated with percutaneous nephrostomy
drainage). Among the four patients primarily treated
with a JJ-stent and percutaneous nephrostomy, sec-
ondary ureterolysis is necessary in only one patient.
In the long term follow-up, a third renal unit loses
all its function, hence a total loss of three renal units
(15%) (one US, two UL). Three chronic pyelo-caliceal
chronic stenoses develop after US (15%). In the whole,
14 renal units (70%) are preserved with normal
function (Table 4). Success rate of early endoureteral
Table 2. Predisposing factors. Incidence is calculated per patient. Cohorts are all AAA (1132) and 10 patients preoperatively affected.
Cohorts for previous surgery and prosthesis infection comprise all patients from AAA and AOD (aortic occlusive disease), i.e. 2297
minus the 10 patients preoperatively affected (2297 2 10 5 2287).
Patient factor Cohort Yes No p value
Inflammatory type (10 patient preop) 1132 AAA 8/40 (20%) 2/1092 (0.2%) ,0.0001
Previous surgery (31 patients) 2297 AAA þ AOD 2 10 ¼ 2287 11/90 (12.2%) 20/2197 (0.9%) ,0.001
Prosthesis infection (31 patients) 2297 AAA þ AOD 2 10 ¼ 2287 3/18 (16.6%) 28/2269 (1.2%) ,0.0001
Treatment of Urological Complications Related to Aorto-iliac Pathology and Surgery 659
Eur J Vasc Endovasc Surg Vol 26, December 2003
treatment alone is 2/7 (29%) in US and 6/7 (86%) in
UL.
Group C (15 patients, 15 US) are treated as follows:
therapeutic abstention ðn ¼ 2Þ; open surgery ðn ¼ 5Þ
for two nephrectomies and three ureterolyses, percu-
taneous nephrostomies ðn ¼ 1Þ; endoscopic treatment
by JJ-stents ðn ¼ 7Þ with two associated percutaneous
nephrostomies. Three out of seven pigtail catheters
necessitate secondary ureterolysis. One isolated per-
cutaneous nephrostomy is followed by secondary
nephrectomy. One of the three primary ureterolyses
is associated with the resection of false aneurysm of
the subrenal aortic-prosthesis suture (Fig. 1). In total,
five nephronic units were lost before or shortly after
treatment; in the long term, two more nephronic units
are lost, hence a total of seven kidneys is lost out of 15
(47%); two chronic stases are observed (13%), so that
only six nephronic units (40%) are preserved and well
functioning (Table 4). Endourological treatment ðn ¼
8Þ necessitates four more open treatments (one
nephrectomy, three ureterolyses) with only one final
success, so that the success rate of endourological
treatment alone is 12.5% in group C.
Discussion
There were 44 iliac lesions vs. 7 lumbar; this iliac
segment vulnerability is due to the fact that the iliac
vessels are almost inevitably dissected during recon-
structive surgery. The role of the inflammatory aneurysm
pathology in the development of preoperative US is
prompted by the fact that, on a total of 40 inflamma-
tory AAA, there are eight patients presenting US (20%)
vs. two patients in the remaining 1092 non-inflamma-
tory aortic aneurysms (0.2%). The presence of hydro-
nephrosis at the time of aneurysm diagnosis must lead
to suspicion of an inflammatory type. Surgery, itself, is
more difficult in inflammatory AAA, resulting in the
occurrence of two malpositions of the prosthesis.
Ureteral lesions may be caused by careless surgery
(perforation, transsection), but also by ischemia (sec-
tion of vascular feeding branches, extensive coagu-
lation), which explains that UL may not be immediate.
Lately, compression (aortic pseudo-aneurysm) or
fibrosis are other mechanisms.
Any redo operation at the site of previous surgery
carries an increased risk: the anatomic positioning of
Table 3. Description of treatment and timing.
Abstention Steroids Nephrostomy JJ-pigtail Ureterolysis Nephrectomy Urovascular fistula
Primary Secondary Primary Secondary
Group A
n patients ¼ 10 0 1 5 9 1 3* 0
n ureters ¼ 16
Group B
Stenosis: 11
n patients ¼ 16 0 1 (1†) 7 3* 0 2
n ureters ¼ 20 0 (4†) 7 0 1* 2
Wounds: 9
Group C
n patients ¼ 15 2 0 1 (2†) 7 3 3* 2 1*
n ureters ¼ 15
Total
n patients ¼ 41 2 2 6 (7†) 30 7 10* 4 1* 2
n ureters ¼ 51
*Secondary.
†Associated with JJ-pigtail.
Table 4. Long-term results.
Kidneys lost (nephrectomy or non functionary) Chronic stasis Success
Group A
n ¼ 16 2 (12%) 3 (19%) 11 (69%)
Group B
n ¼ 20 3 (15%) 3 (15%) 14 (70%)
US ðn ¼ 11Þ 1 3 7 (64%)
UL ðn ¼ 9Þ 2 0 7 (78%)
Group C
n ¼ 15 7 (47%) 2 (13%) 6 (40%)
Total
n ¼ 51 12 (23.5%) 8 (16%) 31 (61%)
P. Bonnet et al.660
Eur J Vasc Endovasc Surg Vol 26, December 2003
the ureter may be modified, its vascularisation may be
already made more vulnerable and dissection is made
more difficult by previous scarring. This well known
fact is again demonstrated in this series; ureteral
complications rate after redo surgery is 12.2% vs. a
0.9% rate in patients not previously operated on.
Early postoperative hydronephrosis rate has a wide
range of incidence rate in literature: from 0.1 to
0.85%,10 10%,13 2 to 20%.14 Usually, the evolution is
spontaneously benign at the end of first 3 months.3,13
Therefore, the actual occurrence rate of silent post-
operative hydronephrosis is not evaluated by clinical
series that take into account only the cases referred to
the Department of Urology, while the presence of
hydronephrosis was not systematically searched for. It
is clear that many US can be asymptomatic. Systematic
search of silent urologic complications was beyond the
scope of this retrospective study and only a few
prospective and limited series had addressed this
issue.15,16
Therapeutic options and results
The treatment aiming to restore the urinary tract
continuity and preserve kidney function, the thera-
peutic choice is made taking into account the type of
lesion, time of occurrence, function of the related
kidney, and patient status. Most ureteral problems can
benefit of improvements in the field of endo-urology
(smaller calibre drains and endoscopes). The endo-
scopic treatment of stenosis (US) or ureteral leakage
(UL) is known for 60 years.17 Ureteral lesions and
pyelo-ureteral lesions are commonly treated using the
internal route.18 – 20 The endoscopic approach is nowa-
days recognized as first line treatment of most ureteral
trauma.21,22 Percutaneous renal drainage under ultra-
sonic guidance allows effective drainage of the
pyelum; JJ-stents placed endoscopically, apart from
drainage, also assure correct alignment of the ureter
during the healing process. Combination of internal
drainage and nephrostomy appeared to be effective in
the treatment of ureteral fistula: the JJ-stent guides
ureteral healing whilst the nephrostomy enforces
drying out of the ureteral leakage which would be
only imperfectly obtained with an isolated internal
drainage (Fig. 3). Thus, percutaneous drainage is also a
useful tool for first line treatment. Placement of the
catheter under local anaesthesia and under ultrasonic
guidance is only slightly invasive and especially
suitable in early follow-up of a major abdominal
surgery operation. Transitory nephrostomy is placed
at time of initial vascular intervention in one third of
patients with preoperative uretero-hydronephrosis;
this aims at improving renal function and not treating
the stenotic lesion. Preoperative JJ-stent used in 9
ureters is also proposed to facilitate its identification
during surgery, but efficacy of preventive drainage as
in other types of surgery (rectal surgery for instance) is
not proved to date.8,11
Pigtail catheters have been widely used, but request
secondary ureterolyses in the third (9/30) of the
patients (Table 3). The need for secondary ureterolysis
minimal in group A (2/9) and in group B UL (1/7),
increases in group B US (3/7) and group C (3/7). But
most importantly, after more than six months of
drainage, two urgent urovascular surgeries are necess-
ary, due to the occurrence of a uretero-prosthesis or
Fig. 2. Uro-vascular fistula with retrogradely perfused
common iliac aneurysm. A, common iliac aneurysm; B,
limb of iliac vascular prosthe`ses; C, external iliac artery; D,
internal iliac artery.27
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uretero-arterial fistula (Table 3 and Fig. 2). To prevent
this life-threatening condition,23 – 28 we limit, now, the
time of JJ drainage. It has been reported that the
drainage period after endopyelotomy or ureteral
incision could be limited to one week,29 but this length
may be too short and we suggest however that a 3-
week drainage should be sufficient enough to obtain
correct healing. Out of seven endourological treated
UL in group B, secondary ureterolysis is needed in one
case only; UL are clearly the best responder to
endourological treatment.
Open surgery has been chosen either as first line
primary treatment in some instances or as secondary
treatment after failure of endosurgery. These surgical
interventions consisted of ureterolysis, nephrectomy
and uncrossing of the urinary and vascular prosthesis
axes. Primarily ureterolysis is performed in long US or
in combination with prosthesis malposition. Second-
ary ureterolysis is performed after failure of endour-
ological treatment. Primary or secondary
nephrectomy is done if pyeloureteral damage is too
important to permit direct reconstruction. Short delay
treatment occurring prior to the formation of scar
tissue and endoureteral approach avoids further
devascularisation by undue dissection. Endourologi-
cal treatment should then be recommended as the
primary therapeutic choice.
Table 4 analyses long-term overall results in the
three groups. Preservation of a nephronic unit without
stasis is quoted as success. We observe a 69, 70 and
40% success rate from groups A, B, and C. Prevalence
of chronic renal stasis, with basically preserved
function, is 19, 15 and 13% in groups A, B, and
C. There are 12, 15 and 47% lost kidneys in groups A, B
and C. These data confirm that the longer the delay for
diagnosis and treatment, the worse the results of
treatment, either with endo-ureteral or open surgery,
or both. Early recognition of the ureteral lesions is the
key element in the success of treatment. Besides in
group B, better results are observed in treatment of UL
than in treatment of US. (78% vs. 64%).
As derived from the reported experience, our
current attitude for early or late ureteral lesions is
illustrated in Fig. 4. When facing early postoperative
Fig. 3. Descending pyelography through nephrostomy tube evidences: (A) Ureteral leakage (UL) of left ureter immediately
treated by JJ-pigtail (JJ) and percutaneous nephrostomy (NEP). (B) Two weeks later. (C) Complete healing at six weeks.
P. Bonnet et al.662
Eur J Vasc Endovasc Surg Vol 26, December 2003
lesions, if the arterial prosthesis is incorrectly posi-
tioned, if the stenosis is long, we choose open surgery
as our first step treatment. If early stenosis is short and
without prosthesis malfunction, and in every case of
ureteral wound leading to UL, we opt for the
endoscopic approach with nephrostomy and/or pla-
cement of a JJ-stent. A 10–15 days drainage with
nephrostomy allows for complete drying out of the
urinary fistula and for early stage ureteral healing.
Thereafter, it will be completed by the internal
drainage of the JJ-stent for no more than three
weeks. For US lately diagnosed, we check first the
functional status of the related kidney; if function is
correct, we proceed to open surgery with no trial of
endourological treatment.
Conclusion
This analysis of 51 ureteral lesions encountered during
14 years of aorto-iliac pathology evaluation and
treatment enables us to further grasp many facts
regarding causative mechanisms and treatment possi-
bilities. The ureteral lesions in the aorto-iliac pathol-
ogy either occur as part of the vascular pathology
process or are of the iatrogenic type. In the first case,
the specific urological treatment aims at re-establish-
ing an optimal renal function. The endo-urological
treatment is especially efficient in these indications. In
post-surgical cases, the frequency of the iatrogenic
lesions will be decreased by a better understanding of
the ureteral anatomy and, particularly, of ureteral
vascularisation. Special attention needs to be given to
operations carried out in multioperated anatomical
sites, which carry a higher risk of ureteral trauma. A
rapid diagnosis of every lesion improves the prognosis
of the ureteral reconstruction, whatever the technique
chosen.
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